InvestorsHub Logo
Followers 67
Posts 3747
Boards Moderated 0
Alias Born 08/30/2009

Re: BBalls-N-CowTown post# 165570

Sunday, 05/16/2021 9:28:44 PM

Sunday, May 16, 2021 9:28:44 PM

Post# of 232396
Misiu,

Gilead inked a collaborative deal with Gritstone Oncology to develop a new vaccine-based immunotherapy with curative potential for HIV. This would mark the first “cure” for HIV, a disease which is typically managed and controlled with antiviral drug cocktails. The deal will see Gilead paying Gritstone $30 million in upfront cash as well as a $30 million equity investment. Gilead will also manage a Phase I trial for the vaccine.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News